SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination Ruby Khatun Khatun16 Dec 2017 3:40 PM ISTNew Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 9:30 AM ISTDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
Nestle, Stada prepare rival bids for Merck consumer health: sources Ruby Khatun Khatun6 Dec 2017 9:00 AM ISTLONDON/FRANKFURT: Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
Roche sues Pfizer to bar biosimilar of cancer drug Herceptin Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTRoche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
Pfizer, Novartis agree UK price cuts for new breast cancer drugs Ruby Khatun Khatun17 Nov 2017 9:45 AM ISTLONDON: Pfizer and Novartis have agreed to price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely...
Bill Gates makes 100 million dollars personal investment to fight Alzheimer Ruby Khatun Khatun15 Nov 2017 10:25 AM ISTLONDON: Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings...
Pfizer Q2 net dips 12 percent at Rs 111.15 crore Ruby Khatun Khatun14 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Pfizer reported a 12 percent dip in standalone net profit to Rs 111.15 crore for the quarter ended September 30, 2017.The company...
Novartis takes fight to Pfizers Ibrance with new Kisqali data Ruby Khatun Khatun10 Nov 2017 10:17 AM ISTZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
Pfizer to launch consumer health sale in November- sources savita thakur thakur27 Oct 2017 3:21 PM ISTLONDON - Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus...
Glenmark gets USFDA nod for chest pain tablets Ruby Khatun Khatun22 Sept 2017 10:47 AM ISTNew Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
